These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 6668669

  • 1. [Enhancement of anti-cancer effect by potential lethal damage repair(PLDR)-inhibitors].
    Akagi K, Sogawa M, Tanaka Y.
    Gan No Rinsho; 1983 Oct; 29(13):1613-8. PubMed ID: 6668669
    [Abstract] [Full Text] [Related]

  • 2. PLDR inhibitors: their biological and clinical implications.
    Nakatsugawa S, Kada T, Nikaido O, Tanaka Y, Sugahara T.
    Br J Cancer Suppl; 1984 Oct; 6():43-7. PubMed ID: 6607738
    [Abstract] [Full Text] [Related]

  • 3. Recovery from potentially lethal damage after X-irradiation in three experimental tumors in mice.
    Shibamoto Y, Takahashi M, Ono K, Komuro C, Abe M.
    Jpn J Cancer Res; 1985 Apr; 76(4):278-83. PubMed ID: 3924702
    [Abstract] [Full Text] [Related]

  • 4. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
    Yuhas JM, Yurconic M, Kligerman MM, West G, Peterson DF.
    Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
    [No Abstract] [Full Text] [Related]

  • 5. [The modification of radiation effect by nucleoside related compounds on a murine tumor given with local radiotherapy and on survival following whole body irradiation].
    Sougawa M, Tanaka Y.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 Oct 25; 49(10):1298-303. PubMed ID: 2616263
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
    Grégoire V, Hunter N, Milas L, Brock WA, Plunkett W, Hittelman WN.
    Cancer Res; 1994 Jan 15; 54(2):468-74. PubMed ID: 8275483
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Concept of therapeutic ratio by combination of radiotherapy and chemotherapy].
    Tanaka Y.
    Gan No Rinsho; 1983 Oct 15; 29(13):1579-83. PubMed ID: 6668667
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H, Choy H, Amorino GP, Kim JS, Cao Q, Hercules SK, DuBois RN.
    Clin Cancer Res; 2001 Oct 15; 7(10):2998-3005. PubMed ID: 11595687
    [Abstract] [Full Text] [Related]

  • 13. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
    Kishi K, Petersen S, Petersen C, Hunter N, Mason K, Masferrer JL, Tofilon PJ, Milas L.
    Cancer Res; 2000 Mar 01; 60(5):1326-31. PubMed ID: 10728694
    [Abstract] [Full Text] [Related]

  • 14. Effects of the nucleoside analogues alpha-ara A, beta-ara A and beta-ara C on cell growth and repair of both potentially lethal damage and DNA double strand breaks in mammalian cells in culture.
    Iliakis G, Bryant PE.
    Anticancer Res; 1983 Mar 01; 3(2):143-9. PubMed ID: 6847132
    [Abstract] [Full Text] [Related]

  • 15. [Problems of antineoplastic effects by PLDR (potential lethal damage repair) inhibitor--pharmacokinetics].
    Sougawa M, Akagi K, Yoshii G, Tanaka Y.
    Gan No Rinsho; 1984 Nov 01; 30(14):1787-92. PubMed ID: 6334757
    [Abstract] [Full Text] [Related]

  • 16. [Apoptosis-inducing and anti-tumor effect of cyclophosphamide, cisplatin and adriamycin used separately or combined in murine lymphosarcoma LS].
    Nikolin VP, Kaledin VI, Baĭmak TIu, Galiamova MR, Popova NA, Voĭtsitskiĭ VE.
    Vopr Onkol; 2002 Nov 01; 48(2):211-5. PubMed ID: 12227071
    [Abstract] [Full Text] [Related]

  • 17. Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect.
    Crokart N, Radermacher K, Jordan BF, Baudelet C, Cron GO, Grégoire V, Beghein N, Bouzin C, Feron O, Gallez B.
    Cancer Res; 2005 Sep 01; 65(17):7911-6. PubMed ID: 16140962
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of the radiation effect by fibrinolysin and quantitative pattern of the change of tumor radiosensitivity.
    Mustafina RH.
    Neoplasma; 1984 Sep 01; 31(3):263-9. PubMed ID: 6234471
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy with [SP-4-3-(R)]-[1,1-cyclobutanedicarboxylato(2-)](2- methyl-1,4-butanediamine-N,N')platinum (CI-973, NK121) in combination with standard agents against murine tumors in vivo.
    Elliott WL, Roberts BJ, Howard CT, Leopold WR.
    Cancer Res; 1994 Aug 15; 54(16):4412-8. PubMed ID: 8044790
    [Abstract] [Full Text] [Related]

  • 20. [The combined action of 2,5,6-H3-DOPA and alkylating agents on Harding-Passy melanoma].
    Ivanov II, Vdovenko VM, Bobrova VN, Gavrilenko IS, Rumiantseva LN.
    Vopr Onkol; 1972 Aug 15; 18(8):76-80. PubMed ID: 4657683
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.